NCT02403856

Brief Summary

Calcific tendinitis of the rotator cuff is a common cause of chronic pain of the shoulder. Needling and lavage of the calcification is one of the therapeutic options after failure of conservative management with physiotherapy and anti-inflammatory drugs. Needling is usually followed by a corticosteroid injection in the subacromial bursae in order to prevent acute pain reaction due to the intervention. However, the relevance of this injection has never been proven. Moreover, corticosteroid could prevent the inflammatory reaction induced by the needling and thus the body's natural calcium resorption processes. Finally, corticosteroids could have deleterious effect on the tendon structures and favour local infection. Our hypothesis is that corticosteroid have no significant effect on acute pain after needling and therefore should not been performed systematically after needling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Apr 2015

Typical duration for phase_4

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 31, 2015

Completed
4 days until next milestone

Study Start

First participant enrolled

April 4, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2017

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

2 years

First QC Date

March 20, 2015

Last Update Submit

October 16, 2018

Conditions

Keywords

calcifying tendinitisNeedle lavageShoulderCorticosteroid injectionUltrasound-guided

Outcome Measures

Primary Outcomes (1)

  • Maximum pain (VAS scale)

    Maximum pain on a VAS scale (0-10) reported by the patient in the seven days following the needling.

    7 days

Secondary Outcomes (24)

  • Anti-inflammatory and analgesic intake

    7 days

  • Size of the calcific deposit

    7 days

  • Size of the calcific deposit

    3 months

  • Size of the calcific deposit

    12 months

  • Number of frozen shoulder in each group

    7 days

  • +19 more secondary outcomes

Study Arms (2)

Experimental group (Sodium Chloride 0.9%)

EXPERIMENTAL

Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of sterile physiological Saline (Sodium Chloride 0.9%) in the subacromial bursae.

Drug: Sodium Chloride 0.9%Procedure: Ultrasound-guided Needling and Lavage

Control group (Methylprednisolone Acetate)

ACTIVE COMPARATOR

Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of methylprednisolone acetate in the subacromial bursae

Drug: Methylprednisolone acetateProcedure: Ultrasound-guided Needling and Lavage

Interventions

Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of sterile physiological Saline (Sodium Chloride 0.9%) in the subacromial bursae.

Also known as: NaCl 0.9%
Experimental group (Sodium Chloride 0.9%)

Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of methylprednisolone acetate in the subacromial bursae

Also known as: Dépomédrol
Control group (Methylprednisolone Acetate)
Control group (Methylprednisolone Acetate)Experimental group (Sodium Chloride 0.9%)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Shoulder pain for at least 3 month
  • Positive Hawkins, Yocum and/or Neer test for impingement
  • Calcific deposit \>= 5 mm on shoulder x-ray in one the tendon of the rotator cuff

You may not qualify if:

  • Allergy to lidocaïne or methylprednisolone acetate
  • Acute pain suggestive of resorption of the calcification with ill-defined - calcification on X-Ray
  • Other shoulder diseases : ostearthritis of the gleno-humeral or acromio-clavicular joint
  • Sonographic findings of rotator cuff tear
  • Subacromial steroid injection in the previous month
  • Uncontrolled diabetes
  • Pregnant women
  • Contraindication for the use of nonsteroidal antiinflammatory drugs or paracetamol/acetaminophene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

La Roche sur Yon Hospital

La Roche-sur-Yon, France

Location

Nantes University Hospital

Nantes, 44093, France

Location

Rennes University hospital

Rennes, France

Location

Related Publications (2)

  • Dumoulin N, Cormier G, Varin S, Coiffier G, Albert JD, Le Goff B, Darrieutort-Laffite C. Factors Associated With Clinical Improvement and the Disappearance of Calcifications After Ultrasound-Guided Percutaneous Lavage of Rotator Cuff Calcific Tendinopathy: A Post Hoc Analysis of a Randomized Controlled Trial. Am J Sports Med. 2021 Mar;49(4):883-891. doi: 10.1177/0363546521992359.

  • Darrieutort-Laffite C, Varin S, Coiffier G, Albert JD, Planche L, Maugars Y, Cormier G, Le Goff B. Are corticosteroid injections needed after needling and lavage of calcific tendinitis? Randomised, double-blind, non-inferiority trial. Ann Rheum Dis. 2019 Jun;78(6):837-843. doi: 10.1136/annrheumdis-2018-214971. Epub 2019 Apr 11.

MeSH Terms

Conditions

Rotator Cuff Tear Arthropathy

Interventions

Sodium ChlorideMethylprednisolone AcetateTherapeutic Irrigation

Condition Hierarchy (Ancestors)

ChondrocalcinosisArthritisJoint DiseasesMusculoskeletal DiseasesCrystal Arthropathies

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsMethylprednisolonePrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsHydrotherapyPhysical Therapy ModalitiesTherapeuticsRehabilitationInvestigative Techniques

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2015

First Posted

March 31, 2015

Study Start

April 4, 2015

Primary Completion

April 2, 2017

Study Completion

November 13, 2017

Last Updated

October 17, 2018

Record last verified: 2018-10

Locations